During the past decade, Kansas City Vascular conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kansas City Vascular" are "Abdominal Aortic Aneurysm" (1 trials) and "Foot Ulcer, Diabetic" (1 trials). Many other conditions were trialed in "Kansas City Vascular" in a lesser frequency.

Most popular intervention types in "Kansas City Vascular" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AFX EVAR AAA Graft System" (1 trials), "FDA Approved EVAR AAA Graft Systems" (1 trials), "PriMatrix Moist Wound Therapy" (1 trials) and "Standard of Care Moist Wound Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Vascular" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kansas City Vascular". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kansas City Vascular, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".